In acute myeloid leukemia, miR-499a-5p suppresses the progression of the disease by promoting the ubiquitin-proteasomal degradation of METTL3, thereby reducing m6A modification levels [47]. The gene discussed is METTL3; the disease is acute myeloid leukemia.